David Gutierrez

David Gutierrez is a scientist currently employed at Lyterian Therapeutics, having commenced the position in September 2023. Prior to this role, David was a Ph.D. candidate at the University of California, Davis, from April 2018 to January 2024, where significant research included solving synthetic challenges related to enantioenriched sulfonimidamides and organizing a collaboration with Merck for high throughput experimentation. Experience also includes a research associate position in the Medicinal Chemistry Department at Gilead Sciences, where David synthesized small molecules and proposed biologically active compounds. Earlier roles included graduate research work at the University of San Francisco, internships at Gilead Sciences in both executive post-baccalaureate and undergraduate capacities, and an undergraduate research assistant role at California Lutheran University. David holds a Ph.D. in Organic Chemistry from the University of California, Davis, a Master's degree in Chemistry from the University of San Francisco, and a Bachelor of Science in Chemistry from California Lutheran University.